tirzepatide weight loss monitoring
Expose Prescription Weight Loss Lies for Clinicians
Tirzepatide delivers greater weight loss than semaglutide, with real-world data showing a 13.6% average reduction at 24 weeks compared with 8.9% for semaglutide. Both agents are GLP-1 receptor agonists administered by injection, but their efficacy and monitoring pathways differ markedly. Medical Disclaimer: This article is for informational purposes